TELO logo
TELO NASDAQ US

Telomir Pharmaceuticals, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Feb 2024
$1.27
▼ $-0.05 (-3.79%)
Vol 87K
2
Quality Score
fail
Mkt Cap
$45.7M
ROE
-335.8%
D/E
0.00
Beta
1.26
52W
$1–$5

Price Chart

Earnings

Beat rate: 40.0%
Next Report May 12, 2026
EPS Estimate: $-0.07
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.07
Dec 2025 $-0.07 $-0.28 $-0.21
Sep 2025 $-0.07 $-0.03 +$0.04
Jun 2025 $-0.08 $-0.17 $-0.09

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -2673.6% -1607.8% -2673.6% -2673.6% -335.8% -335.8%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 2.38 0.75 2.38 2.38 17.51 17.51

Key Ratios

ROA (TTM)
-447.9%
P/B
189.7
EPS (TTM)
$-0.37
52W High
$5.40
52W Low
$1.12
$1.12 52-Week Range $5.40

How does TELO compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

TELO AARD ACB ACRS ADIL

TELO valuation vs Pharmaceuticals peers

P/E ratio
0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
189.7
8849% above peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (2.0%)
vs Peers
vs Industry
Low yield

TELO profitability vs Pharmaceuticals peers

ROE
-335.8%
519% below peers (-54.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-447.9%
1096% below peers (-37.4%)
vs Peers
vs Industry
Weak

TELO financial health vs Pharmaceuticals peers

D/E ratio
0.0
100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
17.5
421% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.3
34% above peers (0.9)
vs Peers
vs Industry
More volatile

TELO fundamentals radar

TELO Peer median Industry

TELO profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

TELO vs peers: key metrics